ALKBH8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.899100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.644400E-02
Normal-vs-Stage2
9.235100E-03
Normal-vs-Stage3
2.262400E-02
Normal-vs-Stage4
3.353000E-01
Stage1-vs-Stage2
8.791200E-01
Stage1-vs-Stage3
2.536500E-02
Stage1-vs-Stage4
4.178200E-01
Stage2-vs-Stage3
5.704000E-02
Stage2-vs-Stage4
3.059200E-01
Stage3-vs-Stage4
5.559800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.942300E-03
Normal-vs-AfricanAmerican
2.479000E-01
Normal-vs-Asian
2.881500E-03
Caucasian-vs-AfricanAmerican
2.522600E-01
Caucasian-vs-Asian
3.182100E-02
AfricanAmerican-vs-Asian
2.660300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.384010E-02
Normal-vs-Female
5.784500E-03
Male-vs-Female
6.440600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.123790E-01
Normal-vs-Age(41-60Yrs)
6.599100E-03
Normal-vs-Age(61-80Yrs)
1.508430E-02
Normal-vs-Age(81-100Yrs)
9.941400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.164800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.747000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.435800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.820430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.346800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.803200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.758100E-03
Normal-vs-Daily Drinker
5.579900E-03
Normal-vs-Weekly Drinker
1.830200E-02
Normal-vs-Occasional Drinker
4.820100E-02
Normal-vs-Social Drinker
7.270100E-02
Non Drinker-vs-Daily Drinker
5.638200E-01
Non Drinker-vs-Weekly Drinker
5.924200E-01
Non Drinker-vs-Occasional Drinker
2.303400E-01
Non Drinker-vs-Social Drinker
6.273200E-01
Daily Drinker-vs-Weekly Drinker
9.561200E-01
Daily Drinker-vs-Occasional Drinker
9.627800E-02
Daily Drinker-vs-Social Drinker
3.689600E-01
Weekly Drinker-vs-Occasional Drinker
1.476000E-01
Weekly Drinker-vs-Social Drinker
4.300600E-01
Occasional Drinker-vs-Social Drinker
6.261400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.706200E-02
Normal-vs-Grade 2
4.344900E-03
Normal-vs-Grade 3
1.960180E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.356800E-01
Grade 1-vs-Grade 3
2.100000E-01
Grade 1-vs-Grade 4
2.706200E-02
Grade 2-vs-Grade 3
4.795200E-01
Grade 2-vs-Grade 4
4.344900E-03
Grade 3-vs-Grade 4
1.960180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.791800E-02
Normal-vs-NonDiabetic
2.175400E-03
Diabetic-vs-NonDiabetic
9.585000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.859800E-03
Normal-vs-NoPancreatitis
6.076000E-03
Pancreatitis-vs-NoPancreatitis
7.460400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.401600E-02
Normal-vs-N1
7.218000E-03
N0-vs-N1
7.076000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.355160E-01
Normal-vs-TP53-NonMutant
3.858200E-01
TP53-Mutant-vs-TP53-NonMutant
4.844600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
